Annual Report 2010/11 - Sonova

84
SALES in CHF m
EBITA in CHF m
1,350
1,200
1,050
900
750
600
450
300
150
0
2006/07 2007/081 2008/09 2009/102 1,650
1,500
2010/11
GRoWTH ACRoSS All REGIoNS
All geographic regions contributed, in local currencies,
to the record sales figures in the financial year 2010/11.
The hearing instruments segment achieved solid performance
in all regions. The EMEA region (Europe, Middle
East, and Africa), including Switzerland, which accounted
for 39.5% of Group sales, performed very well as a result
of rising demand and market share gains. In particular,
key markets such as Germany, Italy, and the United kingdom
performed strongly.
SAlES By REGIoNS
EBITA
margin in %
55.0
50.0
45.0
40.0
35.0
30.0
25.0
20.0
15.0
10.0
5.0
0
1) Excluding one-off costs for the prohibited acquisition of the GN ReSound Group.
2) Restated based on finalization of the acquisition accounting of Advanced Bionics.
in CHF m 2010/11 2009/10
Sales Share Growth in local
currencies
INCOME AFTER TAXES
in CHF m
The temporary recall in the hearing implants segment
impacted results in all regions, with the strongest negative
impact in the United States market. Group-wide, however,
the USA, which remains the strongest single sales market for
Sonova, achieved above-average growth and accounted
for 36.8% of total Group sales in 2010/11.
The Group also achieved solid growth in the rest of
Amer icas region where sales increased, driven mainly by
increased demand for Sonova’s products in Brazil and the
further market penetration in the region. Rest of Americas
accounted for 15.3% of Group sales in financial year
2010/11.
Sales Share
EMEA (excl. Switzerland) 597 37% 12.8% 583 39%
Switzerland 41 3% (9.1)% 45 3%
USA 596 37% 14.3% 547 36%
Americas (excl. USA) 247 15% 24.3% 196 13%
Asia/Pacific 136 8% 2.7% 129 9%
Total sales 1,617 100% 13.3% 1,500 100%
300
250
200
150
100
50
0
CASH-BASED BASIC
EARNINGS PER SHARE in CHF
2006/07 2007/08 1 2008/09 2009/10 2 2010/11
6.00
5.00
4.00
3.00
2.00
1.00
0